These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 19663917)

  • 1. Synergistic anticandidal activity of xanthorrhizol in combination with ketoconazole or amphotericin B.
    Rukayadi Y; Lee K; Lee MS; Yong D; Hwang JK
    FEMS Yeast Res; 2009 Dec; 9(8):1302-11. PubMed ID: 19663917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro anticandidal activity of xanthorrhizol isolated from Curcuma xanthorrhiza Roxb.
    Rukayadi Y; Yong D; Hwang JK
    J Antimicrob Chemother; 2006 Jun; 57(6):1231-4. PubMed ID: 16617064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Candida effects of estragole in combination with ketoconazole or amphotericin B.
    Shin S; Pyun MS
    Phytother Res; 2004 Oct; 18(10):827-30. PubMed ID: 15551395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Vitro antimycotic activity of xanthorrhizol isolated from Curcuma xanthorrhiza Roxb. against opportunistic filamentous fungi.
    Rukayadi Y; Hwang JK
    Phytother Res; 2007 May; 21(5):434-8. PubMed ID: 17236167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of xanthorrhizol against Candida glabrata, C. guilliermondii, and C. parapsilosis biofilms.
    Rukayadi Y; Han S; Yong D; Hwang JK
    Med Mycol; 2011 Jan; 49(1):1-9. PubMed ID: 20560862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro antifungal activity of phenothiazines and their combination with amphotericin B against different Candida species.
    Galgóczy L; Bácsi A; Homa M; Virágh M; Papp T; Vágvölgyi C
    Mycoses; 2011 Nov; 54(6):e737-43. PubMed ID: 21605196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro anti-Malassezia activity of xanthorrhizol isolated from Curcuma xanthorrhiza Roxb.
    Rukayadi Y; Hwang JK
    Lett Appl Microbiol; 2007 Feb; 44(2):126-30. PubMed ID: 17257249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vitro activities of posaconazole, fluconazole, itraconazole, ketoconazole and voriconazole against Candida glabrata].
    Blanco MT; Cañadas J; García-Martos P; Marín P; García-Tapia A; Rodríguez J
    Rev Esp Quimioter; 2009 Sep; 22(3):139-43. PubMed ID: 19662547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic anticandidal activity of pure polyphenol curcumin I in combination with azoles and polyenes generates reactive oxygen species leading to apoptosis.
    Sharma M; Manoharlal R; Negi AS; Prasad R
    FEMS Yeast Res; 2010 Aug; 10(5):570-8. PubMed ID: 20528949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening of Thai medicinal plants for anticandidal activity.
    Rukayadi Y; Shim JS; Hwang JK
    Mycoses; 2008 Jul; 51(4):308-12. PubMed ID: 18331446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro susceptibility testing of Candida and Aspergillus spp. to voriconazole and other antifungal agents using Etest: results of a French multicentre study.
    Mallié M; Bastide JM; Blancard A; Bonnin A; Bretagne S; Cambon M; Chandenier J; Chauveau V; Couprie B; Datry A; Feuilhade M; Grillot R; Guiguen C; Lavarde V; Letscher V; Linas MD; Michel A; Morin O; Paugam A; Piens MA; Raberin H; Tissot E; Toubas D; Wade A
    Int J Antimicrob Agents; 2005 Apr; 25(4):321-8. PubMed ID: 15784312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro synergistic effects of metergoline and antifungal agents against Candida krusei.
    Kang K; Wong KS; Seneviratne CJ; Samaranayake LP; Fong WP; Tsang PW
    Mycoses; 2010 Nov; 53(6):495-9. PubMed ID: 19538518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Biofilm production and antifungal susceptibility patterns of Candida species].
    Yücesoy M; Karaman M
    Mikrobiyol Bul; 2004; 38(1-2):91-8. PubMed ID: 15293907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survey of amphotericin B susceptibility of Candida clinical isolates determined by Etest.
    Chiu YS; Chang SC; Hsueh PR; Wang JL; Sun HY; Chen YC
    J Microbiol Immunol Infect; 2006 Aug; 39(4):335-41. PubMed ID: 16926981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the inhibitory effect of voriconazole on the fungicidal activity of amphotericin B against Candida albicans in an in vitro kinetic model.
    Lignell A; Löwdin E; Cars O; Sjölin J
    J Antimicrob Chemother; 2008 Jul; 62(1):142-8. PubMed ID: 18408237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin.
    Takakura S; Fujihara N; Saito T; Kudo T; Iinuma Y; Ichiyama S
    J Antimicrob Chemother; 2004 Feb; 53(2):283-9. PubMed ID: 14688039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibilities to amphotericin B and fluconazole of Candida species in Taiwan Surveillance of Antimicrobial Resistance of Yeasts 2006.
    Yang YL; Wang AH; Wang CW; Cheng WT; Li SY; Lo HJ;
    Diagn Microbiol Infect Dis; 2008 Jun; 61(2):175-80. PubMed ID: 18304773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of xanthorrhizol isolated from the rhizome of Javanese turmeric (Curcuma xanthorrhiza Roxb.) against Candida albicans biofilms.
    Rukayadi Y; Hwang JK
    Phytother Res; 2013 Jul; 27(7):1061-6. PubMed ID: 22969012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibilities to amphotericin B and fluconazole of Candida species in TSARY 2002.
    Yang YL; Li SY; Cheng HH; Lo HJ;
    Diagn Microbiol Infect Dis; 2005 Mar; 51(3):179-83. PubMed ID: 15766603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amphotericin B-induced in vitro postantifungal effect on Candida species of oral origin.
    Ellepola AN
    Med Princ Pract; 2012; 21(5):442-6. PubMed ID: 22678101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.